Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALTEPARIN vs HEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DALTEPARIN vs HEPARIN: Safety Overview

Metric DALTEPARIN HEPARIN
Total FAERS Reports 3,570 18,167
Deaths Reported 789 3,150
Death Rate 22.1% 17.3%
Hospitalizations 1,443 7,788
Average Patient Age 67.7 yrs 61.3 yrs
% Female Patients 39.7% 40.0%
FDA Approval Date Apr 4, 2002 Approved Prior to Jan 1, 1982
Manufacturer Pfizer Laboratories Div Pfizer Inc Sagent Pharmaceuticals
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Discontinued